Khiron Life Sciences (TSXV:KHRN) announces that it will report Q4 and year-end financial results on April 28, 2020 and webcast Q&A the following day.
- Khiron to report Q4 and Year End Results on April 28, and webcast Q&A will be held the following day
- Khiron finished the 2019 calendar year with approximately $36 Million CAD in cash and working capital
- Khiron and its clinics operational during COVID-19 pandemic under an exemption decreed by the Government of Colombia, without any requirement for further authorization
- Active teleconsultation services complement Khiron’s delivery service that is already delivering medical cannabis prescriptions directly to patients’ homes
- Online education program bringing medical…